Croakey Health MediaProf @[email protected] wraps up the panel discussion with key takeaways = collaboration and importance of thinking about the end before you start #SydneyID2022
The final session of #SydneyID2022 included a discussion about the challenging research funding landscape & suggestions for collaboration & diversifying funding sources.
Final thread👇
@[email protected] can also provide options for in-kind support for International projects & grants if they align with NSW values and strategies
#SydneyID2022
#SydneyID2022
Q from audience – thought about opening up where funding comes from to a more stable source?
A – bound by who we can accept money from, every donor has to go through an ethics process, some won't "cut the muster". #SydneyID2022
A – bound by who we can accept money from, every donor has to go through an ethics process, some won't "cut the muster". #SydneyID2022
A cont – Also important to consider the risk of relying on funds from one source (ie if their funding runs out) – Grimes #SydneyID2022
@[email protected] an example of global charitable foundation - they're not as bound by funding calendars like NHMRC
#SydneyID2022
#SydneyID2022
Questions to consider: If you weren't funded, why should it matter, who would care, who would notice? – @[email protected] #SydneyID2022
In philanthropic proposals, important to frame what the problem is, the solution your research will form part of, & the impact that will be generated
– Grimes #SydneyID2022
– Grimes #SydneyID2022
Philanthropy is more flexible than other types of funding, not tied to particular schemes, but philanthropy interest.
Brings freedom & flexibility, but may be limited in duration (ie difficult to fund clinical trials with philanthropy) – Grimes #SydneyID2022
One of failures in drug-discovery is the difficulties in being able to progress things – @[email protected] #SydneyID2022